400 MODELING, CLINICAL AND VIROLOGY DATA FROM PHASE 2 AND 3...

400 MODELING, CLINICAL AND VIROLOGY DATA FROM PHASE 2 AND 3 STUDIES SUPPORT 12-WEEK TELAPREVIR DURATION IN COMBINATION WITH 24- OR 48-WEEK PEGINTERFERON/RIBAVIRIN DURATION

B. Adiwijaya, T.L. Kieffer, D.J. Bartels, G. Picchio, S. De Meyer, K. Eisenhauer, M. Beumont, N. Adda, C.I. Wright, R.S. Kauffman, V. Garg
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
54
Year:
2011
Language:
english
DOI:
10.1016/s0168-8278(11)60402-9
File:
PDF, 145 KB
english, 2011
Conversion to is in progress
Conversion to is failed